Search results for: 'dect intelligent pharma'

The global penetration rate for smart metering is forecast to increase from just over 40% at the start of 2022 to 65% by 2030. This growth will lead to an increased demand for meter data management (MDM) software. First-generation meters largely focus on basic functions such as billing and time-of-use pricing. With the growth of decentralized energ...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

The global passenger vehicle hands-free driving market is transitioning toward broader commercialization, driven by software-defined vehicle (SDV) architectures, AI-native perception, centralized compute platforms, and lower sensor and compute costs. The market is forecast to soar from $8.9 billion in 2025 to $37.45 billion by 2032, with Level 2+ s...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

13 May 2021  |  Global  |  Market Research

Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market

Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors

Infographics

×

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...

The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...

Cities are responsible for approximately 70% of the world s greenhouse gas (GHG) emissions and are recognized as key players in the transition to a low-carbon economy. The global net zero approach creates growth opportunities for cities to partner with a diverse set of businesses across the value chain to move from decarbonization planning to actio...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This strategic analysis is a part of Frost & Sullivan’s continued coverage of the global enterprise communications platforms and endpoints market as well as the broader, overall enterprise communications marketplace. In this Excel-based deliverable, Frost & Sullivan provides extensive market sizing and market share analysis of the on-premises enter...